Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Bet on These 4 Top-Performing Liquid Stocks for Solid Gains
08:41am, Monday, 03'rd Feb 2025
Investors can boost returns by adding these top-ranked liquid stocks, Alnylam Pharmaceuticals, Frontdoor, EverQuote and Sezzle, to their portfolios.
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
08:00am, Thursday, 30'th Jan 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and
New Strong Buy Stocks for January 27th
07:06am, Monday, 27'th Jan 2025
ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.
GILD vs. ALNY: Which Stock Is the Better Value Option?
12:41pm, Thursday, 23'rd Jan 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Alnylam Pharmaceuticals (ALNY). But which of these two stocks
Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock
10:51am, Thursday, 23'rd Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Best Momentum Stocks to Buy for January 21st
11:11am, Tuesday, 21'st Jan 2025
CDNA, AVXL and ALNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 21, 2025.
Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
10:41am, Tuesday, 21'st Jan 2025
Here is how Alnylam Pharmaceuticals (ALNY) and Medpace (MEDP) have performed compared to their sector so far this year.
New Strong Buy Stocks for January 21st
07:45am, Tuesday, 21'st Jan 2025
CDNA, ALNY, ICL, AVXL and AA have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2025.
ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals
12:26pm, Monday, 13'th Jan 2025
Alnylam reports preliminary fourth-quarter and full-year 2024 product revenues. The company expects to deliver adjusted operating income profitability in 2025.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2024 global net pr
Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025
02:43am, Tuesday, 07'th Jan 2025
Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
10:41am, Wednesday, 25'th Dec 2024
Here is how Alnylam Pharmaceuticals (ALNY) and argenex SE (ARGX) have performed compared to their sector so far this year.
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
02:25pm, Thursday, 19'th Dec 2024
Here, we present four biotech stocks, namely SRPT, ADMA, EXEL and ALNY, which most Wall Street analysts are optimistic about. These companies have upside potential for 2025, backed by strong fundament
What Makes Alnylam (ALNY) a New Buy Stock
01:00pm, Wednesday, 04'th Dec 2024
Alnylam (ALNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference
07:00am, Wednesday, 27'th Nov 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Piper San
